Substituted benzaldehyde compounds and methods for their use in increasing tissue oxygenation
US10034879B2 · kind B2 · utility
34Cited by
43References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 22, 2017 |
| Grant date | Jul 31, 2018 |
| Priority date | — |
| Expiry date | Dec 22, 2037 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02P20/55
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided are substituted benzaldehydes and derivatives thereof that act as allosteric modulators of hemoglobin, methods and intermediates for their preparation, pharmaceutical compositions comprising the modulators, and methods for their use in treating disorders mediate by hemoglobin and disorders that would benefit from increased tissue oxygenation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.